Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Evaluation of the Kidney Disease Developed Malignancy Patients

Can Huzmeli.




Abstract
Cited by 0 Articles

Background: Renal involvement in malignant patients may lead to kidney disease indirectly for a number of reasons, including direct metastasis or dehydration, hyperuricemia, and tumor lysis syndrome. We aimed to evaluate malignant patients who developed kidney disease in our study.
Method: This study was performed in malignant patients who applied to the Kahramanmaras Necip Fazil City hospital between 2015-2017. Blood urea nitrogen, serum creatinine, uric acid, sodium, potassium, calcium, phosphorus, glucose, complete urine output and hemogram were noted in patients with kidney disease.
Results: A total of 688 cancer patients were included in the study. 53.6% of the patients were female and 46.2% were male. The average age of the patients was found as 60.23±13.25 (21-94). Acute kidney injury was detected in %17,1. When the patients diagnosed with kidney disease were evaluated; serum uric acid levels were higher in 46.2% of patients, calcium-level was low in 7.7% of patients and high in 3.6% of patients, serum potassium level was high in 21.1% of patients, phosphorus level was high in 42.9% and serum sodium level was low in 17.2% of patients. According to Kidney Disease Improve Global Outcomes, the acute renal injury was detected in 42.4% of stage-I, 25.4% of stage II, and 32.2% of stage-III. 33 of 118 patients with acute renal injury died.
Conclusion: In our study, the incidence of acute renal injury was 17.1% in the cancer patients. The mortality rate was higher in the patients with the acute renal injury.

Key words: Malignancy, acute renal injury, glomerular filtration rate






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.